ASKA Pharmaceutical : September 14 2023 Newsweek International Features ASKA Pharmaceutical

Press Release

Newsweek International Features ASKA Pharmaceutical

TOKYO, September 14, 2023 - ASKA Pharmaceutical Holdings Co., Ltd. (Head Office: Minato-

ku, Tokyo / President, Representative Director: Takashi Yamaguchi) is pleased to announce that Sohta Yamaguchi, President, Representative Director of its subsidiary, ASKA Pharmaceutical Co., Ltd. (hereinafter "ASKA"), was interviewed by the news agency, the Worldfolio PTE. LTD. and the article introducing ASKA was published in the US weekly magazine "Newsweek International."

Newsweek is an American weekly magazine with a global readership of approximately 46 million people, and provides information on all areas of global culture, politics, economics, and social conditions. Newsweek offered to introduce our company as one of the Japanese companies in the special feature "Japan leads the way in healthcare innovation," resulting in the interview with ASKA.

The full of the interview is posted on the news website "The WORLDFOLIO."; https://www.theworldfolio.com/interviews/aska-we-create-new-value-as-leading-womens-healthcare-company/5872/

* The Worldfolio PTE. LTD. has granted permission to post the article here.

The Worldfolio PTE. LTD.：

The Worldfolio is a media agency and a news website that has been bringing high-quality content to readers around the globe for over 20 years. The Worldfolio PTE LTD is now based in Singapore and provides breaking news, in-depth analyses, and investigative stories about a wide range of topics and sectors, including manufacturing, real estate, construction, healthcare, digital transformation and more.

Media Contacts

ASKA Pharmaceutical Holdings Co., Ltd.

Corporate Planning Department

Tel: +81-3-5484-8366

Email: kouhou@aska-pharma.co.jp